NCT04011800View on ClinicalTrials.gov

PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.

PHASE3RecruitingINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

December 30, 2025

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

Catheter ablation

Pulmonary vein isolation, or additional left or right-sided atrial lesions.

COMBINATION_PRODUCT

Risk Factor Modification

dietary restriction, physical exercise, reduced alcohol intake with antiarrhythmic drugs

Trial Locations (1)

10034

RECRUITING

Cardiocenter, 3rd Medical School, Charles University and University Hospital Kralovske Vinohrady, Prague

All Listed Sponsors
collaborator

General Teaching Hospital, Prague

OTHER

collaborator

Brno University Hospital

OTHER

collaborator

Hospital Podlesi

OTHER

collaborator

Regional Hospital Liberec

OTHER

lead

Charles University, Czech Republic

OTHER